| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 10.21 | -0.10 (-0.97%) | 8.32 - 10.32 | 0.0 |
Market data as of 6:25PM 05/22/13. Quotes are delayed by at least 15 min.
The investment seeks capital appreciation. The fund primarily invests in a diversified portfolio of equity securities of companies that have above-average future growth potential relative to their peers. It will invest in companies of all sizes traded on any stock exchange in the United States. The fund may, from time to time, invest in fixed income securities to preserve capital while seeking yield or if the adviser believes the equity markets are over-valued. It may invest in other investment companies including exchange-traded funds (ETFs) and, occasionally, open-end mutual funds and closed-end funds. The fund is non-diversified.
| Total Return | -0.09% |
|---|---|
| Yield (Trailing 12 Mo.) | 0.00% |
| Expense Ratio | 1.65% |
| Front Load | None |
| Deferred Load | None |
| Minimum Investment | $1,000 |
| Management Tenure | 7 Years |
| Fund Inception | 05/03/2006 |
| Timeframe | BIONX | S&P 500 | Large Growth |
|---|---|---|---|
| 1 Month | 0.00% | 1.93% | 1.25% |
| 3 Month | 3.30% | 7.18% | 5.16% |
| Year-to-Date | 8.50% | 12.74% | 10.16% |
| 1 Year | 0.83% | 16.89% | 10.56% |
| 3 Year | 2.15% | 12.80% | 10.86% |
| 5 Year | -2.11% | 5.21% | 4.47% |
| 10 Year | -- | 7.88% | 7.60% |
| Since Inception | -0.09% | 10.38% | -- |
| Basic Materials | 11.55% | |
|---|---|---|
| Consumer Cyclical | 13.75% | |
| Financial Services | 13.54% | |
| Real Estate | 0.00% | |
| Consumer Defensive | 1.86% | |
| Healthcare | 15.16% | |
| Utilities | 0.00% | |
| Communication Services | 1.70% | |
| Energy | 3.07% | |
| Industrials | 18.07% | |
| Technology | 21.29% |
| By Percent | Short | 0% | Long | Net | |
|---|---|---|---|---|---|
| Stock | -- | 93.66 | 93.66 | ||
| Bond | -- | 0.00 | 0.00 | ||
| Other | -- | 0.00 | 0.00 | ||
| Foreign Stock | -- | 0.44 | 0.44 | ||
| Foreign Bond | -- | 0.00 | 0.00 | ||
| Total | -- | 94.10 | 94.10 | ||
| Cash | -- | 5.90 | 5.90 | ||
| Total Net Assets | $32.65M |
|---|---|
| Total Stock Holdings | 28 |
| Total Bond Holdings | 0 |
| Valuation | BIONX | Category Range |
|---|---|---|
| Price/Earnings | 19.92 | |
| Price/Book | 3.12 | |
| Price/Sales | 1.97 | |
| Price/Cash Flow | 13.53 | |
| Dividend Yield | 0.73 | |
| LT Earnings | 14.4 | |
| Historical Earnings | 20.54 | |
| Sales Growth | 3.37 | |
| Cash-Flow Growth | 13.51 | |
| Book-Value Growth | 8.3 |
| Management Style | |||
|---|---|---|---|
| Large Cap | |||
| Medium Cap | |||
| Small Cap | |||
 |  |  |
| Rating | vs Category | |
|---|---|---|
| Overall |  | |
| Risk | Above Avg | |
| Return | Low |
| Pretax Return | 2.15% |
|---|---|
| Tax-adjusted Return | 2.15% |
| Tax Cost Ratio | 0.00% |
| Potential Cap Gains | -11.95% |
